Non-metro markets generate over a quarter of Metropolis’s revenue with 25% growth, as the diagnostics chain shifts from aggressive lab expansion to increasing network density.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.
